SAA2 and chronic obstructive pulmonary disease: Gao et al. showed that COPD patients with sputum eosinophilia during exacerbation had almost three-fold lower serum SAA levels in the stable phase of the disease when compared to those with neutrophilic phenotype during exacerbations [20].